Trinity Biotech (TRIB) Interest Coverage Ratio (2009 - 2024)

Trinity Biotech has disclosed Interest Coverage Ratio across 16 years of filings, most recently posting 3.41 for Q4 2024.

• Interest Coverage Ratio for Q4 2024 came in at 3.41, up 110.58% year-over-year; the trailing twelve-month figure through Dec 2024 was 2.21 (down 9.22% YoY), and the FY2025 annual result was 0.74, up 66.64% from the prior year.
• Interest Coverage Ratio came in at 3.41 for Q4 2024 at Trinity Biotech, up from 0.83 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 159.82 in Q2 2021 to a low of 222.89 in Q2 2022.
• The 5-year median for Interest Coverage Ratio is 1.13 (2024), against an average of 2.56.
• Across the five-year window, Interest Coverage Ratio tumbled 587.72% in 2020 and jumped 39051.13% in 2021, its largest moves.
• Trinity Biotech's Interest Coverage Ratio stood at 7.41 in 2020, then jumped by 97.47% to 0.19 in 2021, then jumped by 1923.82% to 3.42 in 2022, then plunged by 52.74% to 1.62 in 2023, then soared by 110.58% to 3.41 in 2024.
• The last three Interest Coverage Ratio figures came in at 3.41 (Q4 2024), 0.83 (Q3 2024), and 1.43 (Q2 2024), per Business Quant data.